– Immune Stimulation Augmented by +1,300% at 6-months Post-NPS Treatment – – Statistically Significant Difference of Duration of Immune Response of NPS vs. Control: p=0.000094 - – Data to be Presented Today at the San Antonio Breast Cancer Symposium - NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- SELLAS Life… Read More..

Asset Sale in Preparation for Potential US National Securities Exchange Listing KELOWNA, BC / ACCESSWIRE / December 10, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has closed the sale of its non-pharmaceutical THC-related assets ("the Assets") held… Read More..

Call to be held on Thursday, December 17th at 11:00am EST WOODCLIFF LAKE, N.J., Dec. 10, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases,… Read More..